Jiangsu Recbio Technology Co., Ltd. (02179.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 9Sep 14Sep 17

Key dataSep 17, 2026

OpenHKD 4.90

From 52W high−37.12%

Volume3000.00

Market capHKD 3.04B

P/E (TTM)—

P/S (TTM)279.7x

Div yield—

Key dataSep 17, 2026

Open

HKD 4.90

From 52W high

−37.12%

Volume

3000.00

Market cap

HKD 3.04B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.6x

P/E (TTM)

—

RSI (14)

35.6

MomentumView details →

1D Return

−1.90%

YTD Return

+22.75%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−8.6x

EV/Sales

332.0x

P/S (TTM)

279.7x

P/B (TTM)

5.2x

ProfitabilityView details →

Gross Margin

−509.44%

Net Margin

−5134.34%

EBITDA Margin

−3849.39%

ROE (TTM)

−95.80%

ROA (TTM)

−29.89%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

−68.09%

EPS YoY

+43.38%

FCF YoY

+44.03%

Revenue CAGR 3Y

+32.53%

EPS CAGR 3Y

+3.45%

EBITDA YoY

+38.08%

MomentumView details →

1D Return

−1.90%

YTD Return

+22.75%

1Y Return

−34.53%

RSI (14)

35.6

vs 50D SMA

−1.72%

vs 200D SMA

+0.15%

Capital & dividendView details →

Debt/Equity

1.35x

Current Ratio

0.53x

Quick Ratio

0.45x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.39

EPS Surprise

49.52%

Beats (12Q)

1/12

Next Q EPS Est

−HKD 0.79

Avg Surprise (4Q)

49.52%

Rev Surprise

356.48%

Financials snapshotView financials →

Revenue (TTM)

38.41M

Net Income (TTM)

−1.13B

Op. CF (TTM)

−730.36M

Next earningsApr 1, 2027 →

Latest newsMore news →

RecBio (02179.HK) reported interim results for the six months ended June 2026, with revenue of RMB 47,000, down 99.6% year-on-year, and a narrowed net loss of RMB 212 million, compared with a loss of RMB 341 million in the same period last year.32d ago

Similar companies

MBX Biosciences, Inc. Common StockMBX 蔚蓝生物603739.SH uniQure N.V.QURE Celldex Therapeutics, Inc.CLDX 凯因科技688687.SH Viva Biotech Holdings01873.HK Find similar companies →

Latest newsMore news →

RecBio (02179.HK) reported interim results for the six months ended June 2026, with revenue of RMB 47,000, down 99.6% year-on-year, and a narrowed net loss of RMB 212 million, compared with a loss of RMB 341 million in the same period last year.32d ago